Short stature is the most ubiquitous feature of Turner syndrome (TS). Today, many girls with TS are treated with recombinant human growth hormone (GH) to accelerate growth in childhood and to improve adult height. Here, we will review the history of our understanding of growth in TS, reflect on the path of clinical trials ultimately leading to regulatory approval for clinical use of GH, discuss factors associated with growth outcomes and survey the current unanswered questions about growth and GH in TS
GH therapy has been applied to patients with Turner syndrome for over a decade, but small sample siz...
textabstractShort stature and ovarian failure are the main features in Turner syndrome (TS...
Forty patients with Turner's syndrome, aged 5.0-16.6 yr, were randomly allocated to receive daily sc...
Short stature is considered the most universal clinical feature of Turner syndrome (TS) [1]. The fol...
Growth hormone (GH), alone or in combination with anabolic steroids, seems to improve the growth rat...
textabstractBy definition, 2.3% of the children is born Small for Gestational Age (SGA), which is a...
PurposeShort stature is the most common finding in patients with Turner syndrome. Improving the fina...
Short stature and ovarian failure are the main features in Turner syndrome (TS). To optimize GH and ...
Little is known about factors determining height outcome during GH treatment in Turner syndrome (TS)...
Short stature and ovarian failure are the main features in Turner syndrome (TS). To optimize GH and ...
textabstractSixteen girls with Turner syndrome (TS) were treated for 4 years with biosynthetic growt...
Abstract. Sixteen girls with Turner syndrome (TS) were treated for 4 years with biosynthetic growth ...
Background/PurposeShort stature is a common manifestation of Turner syndrome. The purpose of this st...
Turner syndrome (TS) is a sex-chromosome abnormality in females resulting from partial or complete a...
Abstract Turner's syndrome is the commonest sex chromosome abnormality in females, resulting from t...
GH therapy has been applied to patients with Turner syndrome for over a decade, but small sample siz...
textabstractShort stature and ovarian failure are the main features in Turner syndrome (TS...
Forty patients with Turner's syndrome, aged 5.0-16.6 yr, were randomly allocated to receive daily sc...
Short stature is considered the most universal clinical feature of Turner syndrome (TS) [1]. The fol...
Growth hormone (GH), alone or in combination with anabolic steroids, seems to improve the growth rat...
textabstractBy definition, 2.3% of the children is born Small for Gestational Age (SGA), which is a...
PurposeShort stature is the most common finding in patients with Turner syndrome. Improving the fina...
Short stature and ovarian failure are the main features in Turner syndrome (TS). To optimize GH and ...
Little is known about factors determining height outcome during GH treatment in Turner syndrome (TS)...
Short stature and ovarian failure are the main features in Turner syndrome (TS). To optimize GH and ...
textabstractSixteen girls with Turner syndrome (TS) were treated for 4 years with biosynthetic growt...
Abstract. Sixteen girls with Turner syndrome (TS) were treated for 4 years with biosynthetic growth ...
Background/PurposeShort stature is a common manifestation of Turner syndrome. The purpose of this st...
Turner syndrome (TS) is a sex-chromosome abnormality in females resulting from partial or complete a...
Abstract Turner's syndrome is the commonest sex chromosome abnormality in females, resulting from t...
GH therapy has been applied to patients with Turner syndrome for over a decade, but small sample siz...
textabstractShort stature and ovarian failure are the main features in Turner syndrome (TS...
Forty patients with Turner's syndrome, aged 5.0-16.6 yr, were randomly allocated to receive daily sc...